[New Product] Completion of Development and Launch of FGF2 Alternative Peptide(FGFR1c agonist)
2024/10/01
PeptiGrowth Inc is excited to announce the successful development and launch of a novel synthetic peptide growth factor that exhibits the function of Fibroblast Growth Factor2(FGF2). This groundbreaking peptide, designated as "PG-011", targets the FGFR1c receptor and will be available for purchase starting October 2024.
FGF2 is a well-known growth factor that plays a crucial role in promoting the proliferation and differentiation of various cell types, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs). However, conventional FGF2 is highly unstable, often requiring high concentrations and frequent media changes, which significantly increases costs and operational burdens.
PG-011 overcomes these limitations and offers the following advantages:
Potent Biological Activity: Demonstrates potent cell proliferation-promoting effects on MSCs, iPSCs, and even bovine muscle satellite cells, comparable to FGF2.
Exceptional Stability: Exhibits superior stability compared to FGF2, maintaining its activity for extended periods under various storage and culture conditions.
Reduced Production Costs: Leveraging peptide synthesis technology, PG-011 can be produced at a lower cost than conventional FGF2, making it more affordable.
PG-011 is designed for applications in regenerative medicine and cell agriculture. For free samples, please contact us at [contact].
Press Release
Completion of Development and Launch of FGF2 Alternative Peptide(FGFR1c agonist)
